$505m Pfizer deal ... IMU will get there too!

I know a lot of us long-term IMU shareholders are hurting right now which is why I thought I would post this link to a story that came out yesterday!

https://www.geekwire.com/2018/biotech-startup-kineta-inks-cancer-deal-pfizer-worth-505m/


"Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an agreement with drug giant Pfizer that includes $15 million in upfront payments and the possibility of an additional $505 million down the line.
Like other immunotherapies, Kineta’s treatment uses the body’s natural defenses to attack tumors. By convincing tumor cells that they are infected with a virus, the therapy triggers the same virus-fighting RIG-I Pathway that targets the flu."

IMU are undertaking really ground breaking research. There is no doubt that immunotherapy is the next big thing and Imugene is right at the global forefront of it! The financial rewards will no doubt come and all these clowns selling their shares for 2c will kick themselves in 12 months time. We all just need to keep calm, remain patient and have a little faith that our experienced Board and world-renowned clinical researchers know what they are doing.